Production (Stage)
LeMaitre Vascular, Inc.
LMAT
$81.40
$2.282.88%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.95% | 13.98% | 15.63% | 11.44% | 13.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.95% | 13.98% | 15.63% | 11.44% | 13.60% |
| Cost of Revenue | 9.74% | 9.66% | 6.30% | -3.59% | 3.84% |
| Gross Profit | 12.97% | 16.01% | 20.65% | 19.89% | 18.72% |
| SG&A Expenses | 19.32% | 18.23% | 17.02% | 10.40% | 9.93% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.56% | 10.82% | 9.00% | 2.44% | 6.96% |
| Operating Income | 6.33% | 25.95% | 43.22% | 49.29% | 45.18% |
| Income Before Tax | 11.28% | 23.94% | 48.09% | 50.27% | 59.62% |
| Income Tax Expenses | 11.00% | -0.39% | 46.73% | 65.69% | 47.19% |
| Earnings from Continuing Operations | 11.37% | 32.12% | 48.51% | 46.04% | 63.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.37% | 32.12% | 48.51% | 46.04% | 63.69% |
| EBIT | 6.33% | 25.95% | 43.22% | 49.29% | 45.18% |
| EBITDA | 6.47% | 21.21% | 34.55% | 40.19% | 35.38% |
| EPS Basic | 10.36% | 30.76% | 47.09% | 44.43% | 61.82% |
| Normalized Basic EPS | 10.29% | 22.68% | 46.65% | 46.07% | 52.04% |
| EPS Diluted | 9.09% | 30.04% | 48.48% | 44.44% | 62.96% |
| Normalized Diluted EPS | 9.68% | 21.54% | 45.75% | 45.91% | 51.78% |
| Average Basic Shares Outstanding | 0.92% | 1.02% | 0.96% | 1.10% | 1.15% |
| Average Diluted Shares Outstanding | 1.46% | 1.97% | 1.58% | 1.22% | 1.33% |
| Dividend Per Share | 25.00% | 14.29% | 14.29% | 14.29% | 14.29% |
| Payout Ratio | 0.13% | -0.13% | -0.22% | -0.21% | -0.29% |